Venofer Dosing for Iron Deficiency Anemia
For this 69-year-old, 60 kg female with severe iron deficiency anemia (hemoglobin 95 g/L, ferritin 5 µg/L, iron saturation 5%), administer Venofer 200 mg IV over 2-5 minutes twice weekly for a total of 1000 mg (5 doses over 2.5 weeks).
Rationale for Dosing
This patient has profound iron deficiency with:
- Hemoglobin 95 g/L (9.5 g/dL) - significantly below normal
- Ferritin 5 µg/L - critically low iron stores
- Iron saturation 5% - severe functional iron deficiency
- Stage 3a CKD (eGFR 71 mL/min) - non-dialysis dependent
The FDA label for Venofer 1 establishes that 100-200 mg doses are the standard safe range for non-dialysis CKD patients. Clinical trials in non-dialysis CKD patients used 1000 mg total dose divided over multiple infusions 2, 3.
Administration Schedule
Specific protocol:
- Dose per infusion: 200 mg elemental iron
- Frequency: Twice weekly (e.g., Monday and Thursday)
- Duration: 2.5 weeks (5 total infusions)
- Total cumulative dose: 1000 mg
- Infusion method: IV push over 2-5 minutes 1, 3
This schedule is supported by research showing 200 mg IV push over 5 minutes is effective and safe in non-dialysis CKD patients 3, and the FDA label confirms this dosing for her patient population 1.
Critical Safety Considerations
Do NOT exceed 300 mg per single infusion. Safety data shows 4:
- 200 mg and 300 mg doses over 2 hours: No adverse events
- 400 mg dose: 2/35 patients (5.7%) had hypotension, nausea, back pain
- 500 mg dose: 8/22 patients (36%) had reactions with dizziness, hypotension, nausea
For this specific patient (female, 60 kg, elderly): The 200 mg dose is particularly appropriate as doses ≥500 mg have caused serious hypotension in females weighing <65 kg 2.
Monitoring Protocol
Baseline (completed):
- CBC, ferritin, iron saturation, TIBC ✓
During infusions:
- Observe for 30 minutes post-infusion for hypotension, nausea, or allergic reactions
- Minor reactions occur in <5% of patients 4
Follow-up at 4-6 weeks post-final infusion 5:
- CBC: Expect hemoglobin increase of 1-2 g/dL (10-20 g/L)
- Ferritin: Target >50 ng/mL (µg/L) in absence of inflammation
- Iron saturation: Target >20%
- Do not check iron parameters within 4 weeks of last infusion as circulating iron interferes with assays 5
Expected Outcomes
Based on clinical trial data in similar patients 2, 3:
- Hemoglobin should increase by approximately 1.4 g/dL (14 g/L) by week 6
- Ferritin should increase by approximately 288 ng/mL
- 54% of patients achieve hemoglobin >11 g/dL (110 g/L)
Alternative Consideration
While newer formulations like ferric derisomaltose allow single total-dose infusions up to 1000 mg 5, Venofer (iron sucrose) is NOT FDA-approved for total dose infusion and must be given in divided doses 1. The divided dosing schedule with Venofer is actually advantageous for monitoring tolerance in this elderly patient with CKD.
Common Pitfalls to Avoid
- Do not give >300 mg per infusion - significantly increases adverse event risk
- Do not recheck labs before 4 weeks - will show falsely elevated iron parameters
- Do not dilute in large volumes or infuse slowly - 200 mg can be given as IV push over 2-5 minutes, which is more convenient than 2-hour infusions
- Do not assume oral iron would work - with ferritin of 5 and CKD, IV iron is superior 2, 3